Hepatitis B surface antigen (HBsAg) prevalence in Guatemala

Guatemala: Hepatitis B surface antigen (HBsAg) prevalence was 0.0% in 2024. ◆ Volatile

Latest (2024)
0.0%
World rank
132nd
of 194 countries
All-time high
0.1%
in 2015
All-time low
0.0%
in 2020
Years of data
10
2015–2024

Hepatitis B surface antigen (HBsAg) prevalence in Guatemala, 2015–2024

00.020.040.060.080.12015201920242015: 0.12016: 0.12017: 0.12018: 0.12019: 0.12020: 02021: 02022: 02023: 02024: 0

Source: World Health Organization, Global Health Observatory.

Analysis

In 2024, hepatitis b surface antigen (hbsag) prevalence in Guatemala stood at 0.0%. That is the lowest value across all 10 years on record.

That represents a change of down 100.0% over ten years.

Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Guatemala peaked at 0.1% in 2015 and was at its lowest, 0.0%, in 2020.

Guatemala ranks 132nd of 194 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Hepatitis B surface antigen (HBsAg) prevalence in Guatemala, year by year

Annual values for Hepatitis B surface antigen (HBsAg) prevalence (%) in Guatemala, 2015 to 2024.
Year Value Change
2015 0.1%
2016 0.1% +0.0%
2017 0.1% +0.0%
2018 0.1% +0.0%
2019 0.1% +0.0%
2020 0.0% -100.0%
2021 0.0%
2022 0.0%
2023 0.0%
2024 0.0%

Averages by decade

DecadeAverage LowestHighest Years
2010s 0.1% 0.1% 0.1% 5
2020s 0.0% 0.0% 0.0% 5

Countries ranked near Guatemala

  1. 132 Saudi Arabia 0.0%
  2. 132 El Salvador 0.0%
  3. 132 San Marino 0.0%
  4. 132 Slovakia 0.0%
  5. 132 Slovenia 0.0% compare
  6. 132 Sweden 0.0%
  7. 132 Türkiye 0.0% compare
  8. 132 Uruguay 0.0%
  9. 132 United States of America 0.0%
  10. 132 Andorra 0.0%
  11. 132 United Arab Emirates 0.0%
  12. 132 Argentina 0.0%
  13. 132 Austria 0.0%
  14. 132 Belgium 0.0%
  15. 132 Bulgaria 0.0% compare
  16. 132 Bahrain 0.0%
  17. 132 Belarus 0.0%
  18. 132 Brazil 0.0%
  19. 132 Canada 0.0%
  20. 132 Switzerland 0.0% compare
  21. 132 Chile 0.0%
  22. 132 Cook Islands 0.0%
  23. 132 Colombia 0.0%
  24. 132 Costa Rica 0.0%
  25. 132 Cuba 0.0%
  26. 132 Czechia 0.0%
  27. 132 Germany 0.0%
  28. 132 Ecuador 0.0%
  29. 132 Egypt 0.0% compare
  30. 132 Spain 0.0%
  31. 132 Estonia 0.0%
  32. 132 Finland 0.0%
  33. 132 France 0.0%
  34. 132 United Kingdom of Great Britain and Northern Ireland 0.0% compare
  35. 132 Georgia 0.0%
  36. 132 Greece 0.0%
  37. 132 Honduras 0.0%
  38. 132 Croatia 0.0%
  39. 132 Ireland 0.0%
  40. 132 Iran, Islamic Republic of 0.0%
  41. 132 Iceland 0.0% compare
  42. 132 Italy 0.0%
  43. 132 Japan 0.0% compare
  44. 132 Republic of Korea 0.0% compare
  45. 132 Kuwait 0.0%
  46. 132 Luxembourg 0.0%
  47. 132 Latvia 0.0% compare
  48. 132 Morocco 0.0%
  49. 132 Monaco 0.0%
  50. 132 Mexico 0.0%
  51. 132 Malta 0.0% compare
  52. 132 Montenegro 0.0%
  53. 132 Nicaragua 0.0% compare
  54. 132 Niue 0.0%
  55. 132 Netherlands 0.0%
  56. 132 Norway 0.0% compare
  57. 132 New Zealand 0.0% compare
  58. 132 Panama 0.0%
  59. 132 Poland 0.0%
  60. 132 Portugal 0.0%
  61. 132 Palestine, State of 0.0% compare
  62. 132 Qatar 0.0% compare

See the full ranking of 202 places →

More health data for Guatemala

All data for Guatemala →

Frequently asked questions

What is hepatitis b surface antigen (hbsag) prevalence in Guatemala?
Hepatitis b surface antigen (hbsag) prevalence in Guatemala was 0.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Guatemala?
The highest recorded value was 0.1% in 2015.
What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Guatemala?
The lowest recorded value was 0.0% in 2020.
How does Guatemala rank for hepatitis b surface antigen (hbsag) prevalence?
Guatemala ranks 132nd out of 194 countries with data for 2024.
Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Guatemala?
Over the last ten years it is down 100.0%. The long-run trend across the full record is volatile.
Where does this Guatemala data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Hepatitis B surface antigen (HBsAg) prevalence in Guatemala. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 22 August 2026, from https://health.statizoid.com/stat/hepatitis-b-surface-antigen-hbsag-prevalence-percent/guatemala/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/hepatitis-b-surface-antigen-hbsag-prevalence-percent/guatemala/">Hepatitis B surface antigen (HBsAg) prevalence in Guatemala</a> — Statizoid

About this data

Indicator
Hepatitis B surface antigen (HBsAg) prevalence (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
202 places, 2,020 data points, 2015–2024
Last refreshed